A phase Ib single-arm trial of bintrafusp alfa (BA) for pretreated, locally advanced/unresectable or metastatic (advanced) urothelial cancer (aUC)

被引：0
|
作者：
Grivas, P. [1 ]
Sridhar, S. [2 ]
Perez Valderrama, B. [3 ]
Castellano Gauna, D. E. [4 ]
Loriot, Y. [5 ]
Doger de Speville, B. [6 ]
Pouessel, D. [7 ]
van der Heijden, M. S. [8 ]
Galsky, M. D. [9 ]
Gulati, S. [10 ]
Ravaud, A. [11 ]
Fontana, E. [12 ]
Spira, A. I. [13 ]
Gartrell, B. A. [14 ]
Mortazavi, A. [15 ]
Isambert, N. [16 ]
Baxter, D. [17 ]
Powles, T. B. [18 ]
Khaled, A. H. [19 ]
Morales Barrera, R. [20 ]
机构：
[1] Univ Washington, Dept Med Oncol, Seattle Canc Care Alliance, Seattle, WA USA
[2] UHN, Dept Med Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain
[4] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain
[5] Inst Gustave Roussy, Dept Canc Med, Villejuif, France
[6] Univ Hosp Fdn Jimenez Diaz, Start Madrid Phase 1 Unit, Madrid, Spain
[7] Icr Iuct Oncopole, Dept Med Oncol, Toulouse, France
[8] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[9] Icahn Sch Med, Tisch Canc Inst, Mt Sinai Hosp, New York, NY USA
[10] UC Davis Comprehens Canc Ctr, Hematol & Oncol Dept, Sacramento, CA USA
[11] CHU Bordeaux Hop St Andre, Dept Med Oncol, Bordeaux, France
[12] Sarah Cannon Res Inst SCRI UK, Drug Dev, London, England
[13] Virginia Canc Specialist, Res Inst, Fairfax, VA USA
[14] Montefiore Einstein Ctr Canc Care, Oncol & Urol, Bronx, NY USA
[15] Ohio State Univ, Med Oncol Dept, Wexner Med Ctr, Columbus, OH USA
[16] CHU Poitiers, Dept Med Oncol, Jean Bernard Hop, Poitiers, France
[17] GSK USA, Collegeville, PA USA
[18] St Bartholomews Hosp Barts Hlth NHS Trust, Dept Oncol, London, England
[19] GSK USA, Dept Oncol, Collegeville, PA USA
[20] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2374P
引用
收藏
页码：S1209 / S1210
页数：2
相关论文
共 50 条
  • [1] A phase Ib single-arm study of bintrafusp alfa for the treatment of pretreated, locally advanced/unresectable or metastatic urothelial cancer.
    Grivas, Petros
    Morales-Barrera, Rafael
    Sridhar, Srikala S.
    Loriot, Yohann
    Van der Heijden, Michiel Simon
    Galsky, Matt D.
    Baxter, Dawn
    Khaled, Ahmed Hussein
    Hug, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [2] A phase II, multicenter, single-arm trial of CV301 plus atezolizumab (Atezo) in locally advanced (unresectable) or metastatic urothelial cancer (UC).
    Sonpavde, Guru
    Maughan, Benjamin Louis
    Wei, Xiao X.
    McGregor, Bradley Alexander
    Kilbridge, Kerry L.
    Lee, Richard J.
    Yu, Evan
    Schweizer, Michael Thomas
    Montgomery, Robert B.
    Cheng, Heather H.
    Hsieh, Andrew Caleb
    Birhiray, Ruemu E.
    Gabrail, Nashat Y.
    Nemunaitis, John J.
    Rezazadeh, Arash
    Van Veldhuizen, Peter J.
    Vogelzang, Nicholas J.
    Heery, Christopher Ryan
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [3] A single-arm, phase II, multicenter trial of sunitinib maleate (SU) in locally advanced or metastatic
    Leibowitz-Amit, Raya
    Joshua, Anthony Michael
    Ezzat, Shereen
    Bourdeau, Isabelle
    Olney, Harold
    Oosting, Sjoukje
    Ruether, Joseph D.
    Chin, Soo
    Palmieri, Cristina
    Seah, Jo-An
    Assa, Sylvia L.
    Krzyzanowska, Monika
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [4] Bintrafusp alfa plus paclitaxel for advanced gastric cancer as a second-line treatment: An open label, single-arm, phase Ib/II study.
    Lee, Choong-kun
    Jung, Minkyu
    Park, Sejung
    Kwon, Woo Sun
    Kim, Kyoo Hyun
    Hong, Moonki
    Kim, Hyunwook
    Kim, Hyo Song
    Chung, Hyun Cheol Cheol
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 374 - 374
  • [5] A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma
    Schuetze, Scott M.
    Ballman, Karla V.
    Heise, Rachel
    Ganjoo, Kristen N.
    Davis, Elizabeth J.
    George, Suzanne
    Burgess, Melissa A.
    Choy, Edwin
    Shepard, Dale R.
    Tinoco, Gabriel
    Kelly, Ciara M.
    Hirbe, Angela
    Attia, Steven
    Deshpande, Hari A.
    Schwartz, Gary K.
    Siontis, Brittany L.
    Riedel, Richard F.
    von Mehren, Margaret
    Kozlowski, Erin
    Chen, Helen X.
    Astbury, Caroline
    Rubin, Brian P.
    CLINICAL CANCER RESEARCH, 2024, 30 (20) : 4584 - 4592
  • [6] Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer
    Oaknin, Ana
    Ghamande, Sharad A.
    Kasamatsu, Yuka
    Gil-Martin, Marta
    Grau-Bejar, Juan Francisco
    Garcia-Duran, Carmen
    Sato, Masashi
    Siddiqui, Abdul
    Chaudhary, Surendra Pal
    Vugmeyster, Yulia
    Hasegawa, Kosei
    CLINICAL CANCER RESEARCH, 2024, 30 (05) : 975 - 983
  • [7] An Open-Label, Single-Arm, Phase 2 Trial of the PoloLike Kinase Inhibitor Volasertib ( BI 6727) in Patients With Locally Advanced or Metastatic Urothelial Cancer
    Stadler, Walter M.
    Vaughn, David J.
    Sonpavde, Guru
    Vogelzang, Nicholas J.
    Tagawa, Scott T.
    Petrylak, Daniel P.
    Rosen, Peter
    Lin, Chia-Chi
    Mahoney, John
    Modi, Sanjiv
    Lee, Peter
    Ernstoff, Marc S.
    Su, Wu-Chou
    Spira, Alexander
    Pilz, Korinna
    Vinisko, Richard
    Schloss, Charles
    Fritsch, Holger
    Zhao, Charles
    Carducci, Michael A.
    CANCER, 2014, 120 (07) : 976 - 982
  • [8] Phase I study of TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa (BA) in patients (pts) with metastatic/locally advanced solid unresectable tumours
    Siu, L. L.
    Mckean, M. A.
    Tolcher, A. W.
    Victor, A.
    Kitzing, T.
    Pierre, V.
    Gleicher, S.
    Holland, D. G.
    Richter, E.
    Naing, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S887 - S887
  • [9] First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
    Balar, Arjun V.
    Castellano, Daniel
    O'Donnell, Peter H.
    Grivas, Petros
    Vuky, Jacqueline
    Powles, Thomas
    Plimack, Elizabeth R.
    Hahn, Noah M.
    de Wit, Ronald
    Pang, Lei
    Savage, Mary J.
    Perini, Rodolfo F.
    Keefe, Stephen M.
    Bajorin, Dean
    Bellmunt, Joaquim
    LANCET ONCOLOGY, 2017, 18 (11): : 1483 - 1492
  • [10] Camrelizumab plus nab-paclitaxel in platinum-resistant patients with unresectable locally advanced or metastatic urothelial carcinoma: A multicentre, single-arm, phase II study
    Li, H.
    Chen, M.
    Xue, C.
    Li, L.
    Hu, A.
    Yang, W.
    Zheng, Z.
    Ni, M.
    Zhang, L.
    Zeng, Y.
    Peng, J.
    Yao, K.
    Zhou, F.
    Liu, Z.
    An, X.
    Shi, Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1335 - S1335
12345